³Ô¹ÏÍøÕ¾

Latest AusBiotech News | Page 8

AusBiotech weighs in on Industry Growth Program consultation
Dimerix announces successful completion of second DSMB review of ACTION3 trial
Peter Mac selects BindiMaps to launch Victoria’s first hospital ‘Google Maps for indoors’
Immutep receives positive scientific advice from the European Medicines Agency
New AusBiotech report shows increasing US investment in Australian biotechs
Allarity Therapeutics and FivepHusion announce collaboration for the development of Deflexifol with DRP Companion Diagnostics
AusBiotech responds to research funds consultation
Chimeric receives patent allowance for chlorotoxin in Japan
Neuren Pharmaceuticals wins Bioshares Excellence Award
Dimerix updates on expected timing of DMX-200 Phase 3 kidney trial outcome
Report reviewing gender equity initiatives launched
First patient dosed in study of Telix’s TLX250 with Merck’s peposertib
BioCurate in new partnership with the European Healthtech Venture Builder
Australian company collaborates on US launch of prostate cancer diagnostic
AusBiotech launches ³Ô¹ÏÍøÕ¾ Cell and Gene Manufacturing Blueprint
Industry-led cell and gene manufacturing strategy to develop Australia as APAC hub launched
Henry Schein Medical expands distribution partnership with Lumos Diagnostics
Actinogen CMO presents academic poster to Alzheimer’s Association International Conference
Sensible approach for medtech clinical trials
Pharmaxis reports positive analysis of data from phase 2 PXS-5505 study
Victoria invites expressions of interest for Industry R&D Infrastructure Fund grants
Early-Stage Innovation Forum opens
Lumos completes placement and launches share purchase plan
First cohort dosed in RECCE 327 rapid infusion UTI clinical trial
Build your profile through BiotechDispatch
Moderna submits RSV vaccine to global regulatory agencies
Genetic discovery could help prevent irreversible blindness in people with glaucoma
AusBioNSW General Manager appointed
Cynata Therapeutics announces CEO succession and board changes
Nutromics to progress wearable diagnostic platform with latest capital raise
Takeda’s COCKPI-T programme calls for applications
Neuren opens first site in US for Prader-Willi syndrome Phase 2 trial
AusBiotech calls for journal articles
Imagion Biosystems announces appointment of new CEO
The new ‘Jumar Bioincubator’ calls for biotechnology start-ups
Top performing ASX life science companies
First patient dosed in study of TLX250-CDx exploring indication expansion
AVITA Medical announces FDA approval of RECELL for skin repigmentation in vitiligo patients
WEHI’s Professor Doug Hilton appointed chief executive of CSIRO
Vaxxas opens needle-free vaccine manufacturing site and global HQ in Brisbane
AZD0466 clinical data presented by AstraZeneca at international congress
Views sought on coordination of research funds
Telix opens European radiopharmaceutical production facility
Anteris Technologies reports positive 30 day data from first-in-human study
Former AusBiotech CEO awarded King’s Birthday Honour
Vaxxas appoints former Pfizer executive as chief medical officer
Neuren Pharmaceuticals receives milestone payment from US partner
Clinical Trials One Stop Shop report released